Zosano Pharma - ZSAN Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Zosano Pharma in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" ZSAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ZSAN, but not buy additional shares or sell existing shares.
View ZSAN analyst ratings or view top-rated stocks.

Zosano Pharma Co. (NASDAQ:ZSAN) announced its quarterly earnings data on Friday, May, 13th. The biotechnology company reported ($1.76) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.75) by $0.01. Zosano Pharma had a negative net margin of 8,375.11% and a negative trailing twelve-month return on equity of 177.06%.

Shares of Zosano Pharma reverse split on Tuesday, April 12th 2022. The 1-35 reverse split was announced on Tuesday, April 12th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Zosano Pharma investors own include Aeterna Zentaris (AEZS), Pennsylvania Real Estate Investment Trust (PEI), Bionano Genomics (BNGO), Gran Tierra Energy (GTE), CNBX Pharmaceuticals (CNBX), Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Novan (NOVN), Hallador Energy (HNRG) and EnLink Midstream (ENLC).

(ZSAN) raised $47 million in an initial public offering on Tuesday, January 27th 2015. The company issued 4,300,000 shares at a price of $10.00-$12.00 per share. Ladenburg Thalmann and Roth Capital Partners served as the underwriters for the IPO.

Zosano Pharma trades on the NASDAQ under the ticker symbol "ZSAN."

One share of ZSAN stock can currently be purchased for approximately $0.12.

Zosano Pharma (NASDAQ:ZSAN) has a market capitalization of $582,725.25 and generates $790,000.00 in revenue each year. The biotechnology company earns $-29,920,000.00 in net income (profit) each year or ($14.5034) on an earnings per share basis.

Zosano Pharma's mailing address is 34790 ARDENTECH COURT, FREMONT CA, 94555. The official website for the company is www.zosanopharma.com. The biotechnology company can be reached via phone at (510) 745-1200 or via email at ir@paymentdata.com.